ReviewDiagnostic pathology2024

Response to PD-1 inhibitor in SMARCB1‑deficient undifferentiated rectal carcinoma with low TMB, proficient MMR and BRAF V600E mutation: a case report and literature review.

Wenjuan Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.